PA
OLMA icon

Profund Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Profund Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$873K Buy
58,577
+41,196
+237% +$917K 0.03% 385
2025
Q4 		$435K Buy
+17,381
New +$309K 0.01% 628
2025
Q1 		– Sell
-15,862
Closed -$92.5K – 1074
2024
Q4 		$92.5K Sell
15,862
-2,085
-12% -$20.8K ﹤0.01% 1073
2024
Q3 		$214K Sell
17,947
-961
-5% -$12.3K 0.01% 1014
2024
Q2 		$205K Sell
18,908
-26,310
-58% -$285K 0.01% 976
2024
Q1 		$512K Buy
+45,218
New +$583K 0.02% 567

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Profund Advisors's OLMA Position: Q1 2026 in Review

Profund Advisors increased its Olema Pharmaceuticals (OLMA) stake by 237% in Q1 2026, buying an estimated $917K and bringing the position to 58,577 shares worth $873K. The position accounts for 0.03% of the portfolio, ranked #385.

Profund Advisors first reported a position in OLMA in Q1 2024 and has held it in 6 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Profund Advisors held 58,577 shares of Olema Pharmaceuticals worth $873K as of Q1 2026.
  • Profund Advisors bought 41,196 Olema Pharmaceuticals shares in Q1 2026, an estimated $917K.
  • Olema Pharmaceuticals made up 0.03% of Profund Advisors's portfolio in Q1 2026, its #385 holding.
  • Profund Advisors first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.